Cargando…

Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy

The increasing availability of treatments and the importance of early intervention have stimulated interest in newborn screening for lysosomal storage diseases. Since 2015, 112,446 newborns in North Eastern Italy have been screened for four lysosomal disorders—mucopolysaccharidosis type I and Pompe,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burlina, Alberto B., Polo, Giulia, Rubert, Laura, Gueraldi, Daniela, Cazzorla, Chiara, Duro, Giovanni, Salviati, Leonardo, Burlina, Alessandro P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510225/ https://www.ncbi.nlm.nih.gov/pubmed/33072983 http://dx.doi.org/10.3390/ijns5020024

Ejemplares similares

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021)

Newborn screening for Pompe disease in Italy: Long-term results and future challenges
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
por: Gragnaniello, Vincenza, et al.
Publicado: (2020)

Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study
por: Burlina, Alessandro P., et al.
Publicado: (2019)

Newborn Screening for Fabry Disease: Current Status of Knowledge
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Bone disease in early detected Gaucher Type I disease: A case report
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Neonatal Expanded Screening toward lysosomal storage disorders
por: Burlina, Alberto, et al.
Publicado: (2015)

The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria
por: Burlina, Alessandro P., et al.
Publicado: (2020)

A new strategy of desensitization in mucopolysaccharidosis type II disease treated with idursulfase therapy: A case report and review of the literature
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria
por: Burlina, Alberto, et al.
Publicado: (2016)

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
por: Cazzorla, Chiara, et al.
Publicado: (2014)

Correction to: Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2019)

Unusual Evolution of Hypertrophic Cardiomyopathy in Non-Compaction Myocardium in a Pompe Disease Patient
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018)

Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy
por: Salviati, Alessandro, et al.
Publicado: (2010)

Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2022)

Correction: Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2023)

Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools
por: Gelb, Michael H.
Publicado: (2018)

The Utility of CSF for the Diagnosis of Primary and Secondary Monoamine Neurotransmitter Deficiencies
por: Burlina, A.B., et al.
Publicado: (2017)

Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia
por: Peng, Gang, et al.
Publicado: (2018)

Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges
por: Smith, Laurie D., et al.
Publicado: (2020)

Increased detection of primary carnitine deficiency through second-tier newborn genetic screening
por: Lin, Yiming, et al.
Publicado: (2021)

Evidence of Dirofilaria immitis in Felids in North-Eastern Italy
por: Grillini, Marika, et al.
Publicado: (2022)

Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy
por: Manica, Mattia, et al.
Publicado: (2021)

Implementation of second-tier tests in newborn screening for the detection of vitamin B(12) related acquired and genetic disorders: results on 258,637 newborns
por: Pajares, Sonia, et al.
Publicado: (2021)

Health-related quality of life in a european sample of adults with early-treated classical PKU
por: Maissen-Abgottspon, Stephanie, et al.
Publicado: (2023)

Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests
por: Wang, Li-Yun, et al.
Publicado: (2013)

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I
por: Peck, Dawn S., et al.
Publicado: (2020)

Correction to: implementation of second-tier tests in newborn screening for the detection of vitamin B12 related acquired and genetic disorders: results on 258,637 newborns
por: Pajares, Sonia, et al.
Publicado: (2023)

Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021)

Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan
por: Shigematsu, Yosuke, et al.
Publicado: (2021)

Institutions and the uneven geography of the first wave of the COVID‐19 pandemic
por: Rodríguez‐Pose, Andrés, et al.
Publicado: (2021)

Impact of tiered measures on social contact and mixing patterns of in Italy during the second wave of COVID-19
por: Tizzani, Michele, et al.
Publicado: (2023)

Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
por: Ruoppolo, Margherita, et al.
Publicado: (2022)

Niemann–Pick disease type C: introduction and main clinical features
por: Burlina, A.
Publicado: (2014)

The Value of Very Good “Second Tier” Journals
por: King, Spencer B.
Publicado: (2020)

Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses
por: Tangeraas, Trine, et al.
Publicado: (2020)

Cystic Fibrosis Newborn Screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters
por: Zeyda, Maximilian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v02r3e68o71bt4vejve24d2pl